Kneat.com, Inc.

Kneat.com, Inc.

KSIOF
Kneat.com, Inc.US flagOther OTC
3.90
USD
+0.05
- -
373.57MMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
0.04
- -
0.01
0.03
0.07
0.11
0.21
0.31
0.44
0.57
0.67
0.7
Basic EPS, GAAP
-1.52
-0.06
-0.04
-0.03
-0.09
-0.09
-0.11
-0.09
-0.13
-0.12
-0.19
-0.09
-0.02
-0.09
Free Cash Flow per Basic Share
-0.03
-0.04
-0.07
-0.15
-0.12
-0.14
-0.12
-0.14
-0.1
-0.13
-0.24
-0.12
-0.1
-0.21
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
0.06
0.82
0.12
0.12
0.14
0.25
0.4
0.29
0.11
0.68
0.66
0.64
Tangible Book Value per Share
0.57
-0.02
0.02
0.69
0.07
0.06
0.09
0.15
0.28
0.09
-0.17
0.33
0.2
0.18
Basic Weighted Avg Shares
26
27
26
19
43
50
59
66
74
77
78
87
95
95
Sales/Revenue/Turnover
- -
- -
1
- -
- -
1
4
7
16
24
34
49
63
67
Operating Margin (%)
- -
- -
-99.55
- -
-1,016.42
-395.36
-128.78
-88.35
-40.99
-41.16
-40.72
-12.15
-13.35
-14.09
Depreciation Expense
- -
- -
1
- -
1
2
2
3
4
6
8
10
14
15
Net Income, GAAP
-40
-2
-1
-1
-4
-5
-6
-6
-10
-9
-15
-8
-2
-8
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-102.32
- -
-948.31
-352.52
-156.88
-76.68
-63.6
-38.52
-42.43
-15.79
-3.71
-12.69
Working Capital
1
- -
1
- -
3
2
4
7
18
5
6
44
30
24
LT Debt
- -
1
1
1
1
- -
1
9
7
7
28
25
21
18
Total Equity
15
1
2
15
7
8
11
19
34
26
16
65
65
63
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-1,840.16
-113.17
-5.97
-39.28
-82.8
-86.02
-46.04
-42.65
-35.19
-94.93
-22.98
-3.87
-13.68

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
7
8
9
LT Borrowings
16
14
12
LT Finance Leases
7
7
6
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
95
96
96
Market Capitalization
565
461
335

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
73
66
81
Cash, Cash Equivalents & STI
60
49
52
Accounts Receivable, Net
8
7
23
Inventories
- -
- -
- -
Total Current Liabilities
43
36
57
Payables & Accruals
9
8
7
ST Debt
7
8
9
Deferred Revenue
25
19
39

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
98%
63.89%
-0.08%
Free Cash Flow
26.19%
9.85%
-3.21%
Net Income, GAAP
69.42%
1.67%
-69.61%
Sales/Revenue/Turnover
- -
55.69%
29.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
11
12
13
14
49
2025
15
15
16
17
63
2026
18
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.04
-0.04
0.01
- -
-0.09
2025
0.02
- -
-0.01
-0.04
-0.02
2026
-0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Edmund Ryan
Full Time Employees
297
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
Castletroy Business Park Limerick Ireland V94 KW28
IPO Date
Jul 1, 2014
Website
kneat.com
Business
Kneat.com, Inc. is a technology company specializing in the development and provision of software solutions for life sciences and regulated industries. The company offers a comprehensive digital validation platform that automates and streamlines validation, commissioning, qualification, and other compliance processes. Its core products include software for digital validation lifecycle management, electronic workflows, data capture, and documentation control, designed to replace manual, paper-based validation systems. Kneat’s platform facilitates quality assurance, regulatory compliance, and operational efficiency for pharmaceutical, biotechnology, and medical device companies. Operating primarily in North America, Europe, and Asia, Kneat.com serves customers globally from its headquarters in Dublin, Ireland. Founded in 2008, the company delivers a cloud-based SaaS platform tailored to highly regulated environments. In the past two years, Kneat.com has expanded its market reach and product capabilities through strategic partnerships and acquisitions. A significant development includes the launch of new advanced modules enhancing user experience and integration with leading enterprise systems used in regulated industries. These improvements are aimed at accelerating digital transformation and compliance automation in client operations. The company has also secured additional funding to support global growth and continuous innovation. Additionally, Kneat.com has invested in expanding its sales and customer support footprint to better serve its international clientele. There have been no recent name changes or major reorganizations reported. Kneat.com, Inc. competes in the life sciences software industry, focusing on digital transformation of validation and compliance workflows. Its customers primarily include pharmaceutical manufacturers, contract development and manufacturing organizations (CDMOs), biotechnology firms, and medical device manufacturers. The company's software enables these entities to maintain regulatory compliance with agencies such as the FDA and EMA by providing a more efficient and reliable method for validation lifecycle management compared to traditional manual systems. Kneat.com continues to enhance its platform to address evolving industry requirements and technological advancements, positioning itself as a key player in the digital compliance and validation space.

Company News

APIChat
  • Kneat Announces Results of Voting at Annual General Meeting

  • kneat.com Q1 Earnings Call Highlights

  • kneat.com, inc. (KSI:CA) Q1 2026 Earnings Call Transcript

  • Kneat Announces Record Revenue for First Quarter 2026

  • Kneat.com Responds to Press Report

  • Kneat.com Responds to Press Report

  • 2026 State of Validation Study Reveals Significant Headroom Remains for Further Digitization

  • Leading CDMO Selects Kneat to Power Digital Validation Transformation

  • Kneat to Announce 2026 First-Quarter Financial Results May 13, 2026

  • kneat.com, inc. (KSI:CA) Q4 2025 Earnings Call Transcript

  • Kneat Releases 2025 Annual Shareholder Letter Highlighting Resilience, Opportunities Presented by Artificial Intelligence

  • Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2025

  • kneat.com (OTC:KSIOF) Trading Down 0.1% – Here’s What Happened

  • Global Pharmaceutical Packaging Manufacturer Selects Kneat

  • Kneat to Announce 2025 Fourth-Quarter and Year-End Financial Results February 25, 2026

  • Global Biopharma Solutions Leader Selects Kneat to Drive Digital Validation Excellence

  • Global Specialty Chemicals Leader Chooses Kneat for Digital Validation

  • kneat.com, inc. (KSI:CA) Q3 2025 Earnings Call Transcript

  • Kneat Announces Record Revenue for Third Quarter 2025

  • Global Technology Manufacturer Selects Kneat to Drive Digital Transformation Across Enterprise and Manufacturing Sites